Tempest Therapeutics (TPST) Total Liabilities (2011 - 2026)
Tempest Therapeutics (TPST) posted Total Liabilities of $10.3 million for Q4 2025, down 4.82% sequentially from $10.8 million in Q3 2025, and down 54.11% YoY from $22.4 million in Q4 2024.
Tempest Therapeutics (TPST) Total Liabilities (2011 - 2026) Analysis & Trends
Tempest Therapeutics has reported Total Liabilities for 15 years, with the latest figure at $10.3 million in Q4 2025.
- Quarterly Total Liabilities fell 54.11% year-over-year to $10.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $10.3 million (down 54.11% YoY) and the FY2025 annual result came in at $10.3 million, down 54.11% from the prior year.
- Total Liabilities declined to $10.3 million in Q4 2025 per TPST's latest filing, from $10.8 million in the prior quarter.
- Over five years, Total Liabilities peaked at $37.6 million in Q1 2022 and troughed at $10.3 million in Q4 2025.
- A 5-year average of $25.8 million and a median of $25.2 million in 2023 frame the typical range for Total Liabilities.
- The sharpest annual moves came in 2021 and 2025: Total Liabilities jumped 650.07% in 2021, then tumbled 54.11% in 2025.
- Over 5 years, Total Liabilities stood at $37.1 million in 2021, then retreated by 24.63% to $28.0 million in 2022, then decreased by 11.23% to $24.8 million in 2023, then dropped by 9.96% to $22.4 million in 2024, then sank by 54.11% to $10.3 million in 2025.
- According to Business Quant data, Total Liabilities over the past three periods registered $10.3 million, $10.8 million, and $14.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 10.03 Bn |
| 10 | Tempest Therapeutics | 4.23 Mn | 3.43 Mn | - | 10.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.72 Mn |
| Dec 31, 2025 | 10.26 Mn |
| Sep 30, 2025 | 10.78 Mn |
| Jun 30, 2025 | 14.70 Mn |
| Mar 31, 2025 | 21.03 Mn |
| Dec 31, 2024 | 22.36 Mn |
| Sep 30, 2024 | 22.38 Mn |
| Jun 30, 2024 | 25.23 Mn |
| Mar 31, 2024 | 23.75 Mn |
| Dec 31, 2023 | 24.84 Mn |
| Sep 30, 2023 | 25.18 Mn |
| Jun 30, 2023 | 25.73 Mn |
| Mar 31, 2023 | 26.36 Mn |
| Dec 31, 2022 | 27.98 Mn |
| Sep 30, 2022 | 36.40 Mn |
| Jun 30, 2022 | 36.42 Mn |
| Mar 31, 2022 | 37.60 Mn |
| Dec 31, 2021 | 37.12 Mn |
| Sep 30, 2021 | 23.61 Mn |
| Jun 30, 2021 | 27.38 Mn |